BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 10642610)

  • 1. Urinary excretion of glycosaminoglycans and albumin in experimental diabetes mellitus.
    Cadaval RA; Kohlman O; Michelacci YM
    Glycobiology; 2000 Feb; 10(2):185-92. PubMed ID: 10642610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and urinary glycosaminoglycans in an experimental model of chronic renal failure in rats.
    Michelacci YM; Cadaval RA; Rovigatti RM; Kohlman O
    Exp Nephrol; 2001; 9(1):40-8. PubMed ID: 11053979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of dermatan sulfate and heparan sulfate in the urine of a patient with the Hunter syndrome.
    Kimura A; Hayashi S; Tsurumi K
    Tohoku J Exp Med; 1980 Jul; 131(3):227-39. PubMed ID: 6447930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in cat urinary glycosaminoglycans with age and in feline urologic syndrome.
    Pereira DA; Aguiar JA; Hagiwara MK; Michelacci YM
    Biochim Biophys Acta; 2004 Apr; 1672(1):1-11. PubMed ID: 15056487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of fasting and time of day on the urinary excretion of chondroitin 4/6 sulphate, dermatan sulphate and four chondroitinase ABC resistant glycosaminoglycans.
    Poulsen JH; Gregersen H
    Scand J Clin Lab Invest; 1983 Dec; 43(8):665-70. PubMed ID: 6420878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats.
    Reddi AS; Ramamurthi R; Miller M; Dhuper S; Lasker N
    Biochem Med Metab Biol; 1991 Feb; 45(1):119-31. PubMed ID: 2015105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced urinary excretion of sulfated polysaccharides in diabetic rats.
    de Lima CR; Aguiar JA; Michelacci YM
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):30-41. PubMed ID: 15955447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of hepatic glycosaminoglycans in the early stages of galactosamine hepatitis: a rapid decline of heparan sulfate is followed by elevation of chondroitin sulfate and dermatan sulfate.
    Gressner AM; Köster-Eiserfunke W
    J Clin Chem Clin Biochem; 1981 Jun; 19(6):363-70. PubMed ID: 6456325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of diltiazem on glomerular heparan sulfate and albuminuria in diabetic rats.
    Jyothirmayi GN; Reddi AS
    Hypertension; 1993 Jun; 21(6 Pt 1):795-802. PubMed ID: 8500860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced sulfation of chondroitin sulfate but not heparan sulfate in kidneys of diabetic db/db mice.
    Reine TM; Grøndahl F; Jenssen TG; Hadler-Olsen E; Prydz K; Kolset SO
    J Histochem Cytochem; 2013 Aug; 61(8):606-16. PubMed ID: 23757342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of albuminuria by captopril in diabetic rats.
    Reddi AS
    Gen Pharmacol; 1991; 22(2):323-8. PubMed ID: 2055428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosaminoglycan content in tissues and body fluids of rats treated with atherogenic diet.
    Drózdz M; Kucharz E; Głowacki A
    Acta Biol Med Ger; 1979; 38(10):1473-7. PubMed ID: 121507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of urinary glycosaminoglycans excreted by a patient with the Hurler-Scheie compound syndrome.
    Kimura A; Hayashi S; Koseki M; Tsurumi K
    Tohoku J Exp Med; 1982 Jan; 136(1):61-6. PubMed ID: 6803394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polydispersity of glycosaminoglycans in normal human urine.
    Endo M; Namiki O; Yosizawa Z
    Tohoku J Exp Med; 1980 Aug; 131(4):327-37. PubMed ID: 6781104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heterogeneity of dermatan sulfate and heparan sulfate in rat liver and a shift in the glycosaminoglycan contents in carbon tetrachloride-damaged liver.
    Suzuki S; Suzuki S; Nakamura N; Koizumi T
    Biochim Biophys Acta; 1976 Mar; 428(1):166-181. PubMed ID: 130930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosaminoglycans of rat colorectal adenocarcinoma.
    Isemura M; Munakata H; Ototani N; Goto K; Yosizawa Z
    Gan; 1982 Oct; 73(5):721-7. PubMed ID: 6819975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of urinary stone disease and extracorporeal shockwave lithotripsy on excretion of glycosaminoglycans.
    Erkurt B; Ilker Y; Budak Y; Ozveren B; Türkeri L; Akdas A
    J Endourol; 1999 Oct; 13(8):553-7. PubMed ID: 10597124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary glycosaminoglycan excretion as a biochemical marker in patients with bladder carcinoma.
    Hennessey PT; Hurst RE; Hemstreet GP; Cutter G
    Cancer Res; 1981 Oct; 41(10):3868-73. PubMed ID: 6793229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and turnover of glycosaminoglycans in rat kidneys.
    Barry DN; Bowness JM
    Can J Biochem; 1975 Jun; 53(6):713-20. PubMed ID: 124622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans.
    de Ru MH; van der Tol L; van Vlies N; Bigger BW; Hollak CE; Ijlst L; Kulik W; van Lenthe H; Saif MA; Wagemans T; van der Wal WM; Wanders RJ; Wijburg FA
    J Inherit Metab Dis; 2013 Mar; 36(2):247-55. PubMed ID: 22991166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.